NWBO实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (30 Apr 2024 @ 03:59):

Stats
今日成交量	1.33M
平均成交量	1.73M
市值	562.62M
EPS	$0 ( 2024-02-29 )
下一个收益日期	( $0 ) 2024-05-08
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-7.88
ATR14	$0.00300 (0.63%)

Insider Trading

Date	Person	Action	Amount	type
2023-11-16	Malik Navid	Buy	125 000	Common Stock
2023-11-17	Malik Navid	Buy	150 000	Common Stock
2023-11-17	Malik Navid	Buy	295 000	Common Stock
2023-04-03	Bosch Marnix L	Buy	119 355	Common Stock
2023-04-04	Boynton Alton L	Sell	6 794 191	STOCK OPTIONS

INSIDER POWER
-81.43
Last 96 transactions
Buy: 331 589 317 \| Sell: 61 146 214

音量相关性

長: 0.00 (neutral)

短: 0.09 (neutral)

Signal:(53.692) Neutral

Northwest 相关性

10 最正相关

10 最负相关

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Northwest 相关性 - 货币/商品

0.44
( neutral )

0.49
( neutral )

0.00
( neutral )

-0.51
( weak negative )

Northwest 财务报表

Annual	2023
营收:	$1.93M
毛利润:	$199 000 (10.30 %)
EPS:	$-0.0559

FY	2023
营收:	$1.93M
毛利润:	$199 000 (10.30 %)
EPS:	$-0.0559

FY	2022
营收:	$1.68M
毛利润:	$135 000 (8.02 %)
EPS:	$-0.130

FY	2021
营收:	$1.01M
毛利润:	$0.00 (0.00 %)
EPS:	$0.210

Financial Reports:

No articles found.

Northwest

Northwest Biotherapeutics, Inc., a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient's own immune system to attack cancer. Its lead product, DCVax-L, which has completed Phase III clinical trials to treat Glioblastoma multiforme brain cancer. The company also develops DCVax-Direct, which is in Phase I/II clinical trials to treat inoperable solid tumors. The company was founded in 1996 and is headquartered in Bethesda, Maryland.